How Wazoku Solved Challenges in Oncology

Driving Innovation in Cancer Research

The fight against cancer requires bold, innovative approaches that push beyond traditional boundaries. Through collaboration with Wazoku’s global network of innovators, organizations like Sanofi are identifying novel solutions to some of the most complex challenges in oncology. By leveraging the power of crowdsourced innovation, the Wazoku Crowd has helped accelerate the discovery of groundbreaking cancer treatments, diagnostic tools, and therapeutic targets that are transforming patient care.

In this blog, we explore how multiple cancer-related Challenges have been successfully solved through open innovation and highlight the incredible breakthroughs made possible by engaging a diverse community of experts. From identifying novel therapeutic concepts to advancing precision medicine strategies, these challenges showcase the impact of collaborative problem-solving in the field of oncology.

Join the journey of innovation and see how crowdsourcing can help solve the biggest challenges in cancer treatment and beyond.

Novel Therapeutic Concepts to Treat Cancer

Despite recent advancements in cancer research, many types of cancer still lacked curative or highly effective therapeutic options. To address this, Wazoku’s Open Innovation platform presented a challenge seeking novel therapeutic concepts for cancer treatment. This challenge encouraged groundbreaking approaches to improve patient outcomes, particularly focusing on synthetic lethality—an approach that targeted cancer cells with specific gene mutations while sparing normal cells.

The Seeker was particularly interested in major solid tumors with significant unmet needs, such as breast, lung, colon, and prostate cancer. Participants were asked to propose molecular targeting approaches that utilized the synthetic lethality concept, with a detailed rationale and potential strategies for drug candidate identification.

Key requirements for the proposed solution:

• Target identification: Focus on tumor suppressor genes or oncogenes relevant to solid tumors.
• Scientific rationale: Provide supporting data, including in vitro, in vivo, or published data, to justify the approach.
• Novelty: The Seeker is looking for unprecedented approaches not already in clinical or preclinical development.

How the Wazoku Crowd Solved the Oncology Innovation Challenge Solvers proposed breakthrough molecular targets and synthetic lethality strategies that offer potential for personalized cancer treatments. These innovative solutions aim to significantly improve outcomes in patients with hard-to-treat cancers, paving the way for future clinical trials and therapies.

Early Diagnostic Tools for Pancreatic Cancer

Pancreatic cancer was one of the deadliest cancers, often diagnosed too late for effective treatment. With a 5-year survival rate of less than 5%, its silent progression made it difficult to detect at early stages. However, if diagnosed early, particularly in stage 1, the survival rate rose to 21%.

This challenge sought innovative diagnostic tools capable of detecting pancreatic cancer early. The goal was to identify tools or sets of tools that could pinpoint stage 1 pancreatic cancer, when the disease was asymptomatic and largely undetected.

Key requirements for the proposed solution:

• Sensitivity and specificity: The diagnostic tool had to be highly sensitive, able to detect early-stage pancreatic cancer before symptoms arose.
• Ease of implementation: It needed to be practical for healthcare providers and fit into routine medical practices.
• Novelty: The Seeker was looking for truly breakthrough diagnostic approaches, such as biomarkers in body fluids or other cutting-edge methods that could change the way pancreatic cancer was detected.

How the Wazoku Crowd Solved the Oncology Innovation Challenge: Through global collaboration, solvers proposed innovative tools, including biomarker-based diagnostics and imaging advancements, offering hope for early detection of this devastating cancer. These solutions hold the potential to save lives by diagnosing pancreatic cancer before it progresses to advanced stages.

Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Novel Targets for Drug Discovery in Cancer Patients

The Seeker successfully partnered with innovators from the Wazoku Crowd to identify and develop novel oncology targets for precision medicine, aiming to block tumor growth in specific patient populations. This Challenge attracted groundbreaking solutions from experts worldwide, resulting in multiple promising targets for collaboration and development.

The Challenge focused on tackling the heterogeneity of human cancer cells, which complicated finding universal cancer therapies. By leveraging the expertise of the Wazoku Crowd, the Seeker identified specific genetic contexts where targeted therapies could disrupt critical proteins or pathways essential for cancer cell survival. These solutions helped the Seeker advance precision medicine strategies for major cancer indications like breast cancer, gastrointestinal/colorectal cancers, NSCLC, prostate cancer, and multiple myeloma.

How the Wazoku Crowd Solved the Oncology Innovation Challenge

The Wazoku community offered actionable targets and comprehensive proposals, focusing on areas such as:

• Activation of signaling pathways (e.g., KRAS)
• Resistance mechanisms to existing therapies
• Synthetic lethality approaches targeting gene suppressor alterations

Each submission provided a detailed exploration of the target’s function, target validation data, and key experiments necessary for further development.

Wazoku Open Innovation in Oncology

Wazoku’s Open Innovation platform has proven to be a powerful tool for solving complex challenges. By bringing together a global community of solvers, Wazoku helps leading organizations in the Health and Life Sciences industry tackle their toughest problems, drive innovation, and improve patient outcomes.

Whether through cutting-edge technologies like AI, precision medicine, or patient-centered research, Wazoku Crowd continues to push the boundaries of what’s possible in healthcare innovation.

Interested in driving innovation for your organization?

Run your own challenge and unlock the power of global collaboration to solve your toughest problems.

Explore